ソフトカプセルの世界市場

ソフトカプセルの世界市場は2030年までに米国で114億米ドルに達する見込み

2024年に85億米ドルと推定されるソフトカプセルの世界市場は、2024年から2030年にかけてCAGR 5.0％で成長し、2030年には114億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるゼラチンベース／動物ベースは、CAGR 4.1％を記録し、分析期間終了時には74億米ドルに達すると予測されます。非動物性セグメントの成長率は、分析期間中CAGR6.9％と推定されます。

米国市場は23億米ドルと推定、中国はCAGR 7.8％で成長すると予測

米国のソフトカプセル市場は、2024年に23億米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 7.8%で推移し、2030年までに22億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.5％と5.0％と予測されています。欧州では、ドイツがCAGR 3.2%で成長すると予測されています。

世界のソフトカプセル市場- 主要動向と促進要因のまとめ

なぜソフトカプセルは市場で人気を集めているのか？医薬品、栄養補助食品、化粧品におけるソフトカプセルの役割を理解する

ソフトカプセルは、摂取のしやすさ、バイオアベイラビリティの向上、保存期間の延長により、医薬品、栄養補助食品、化粧品業界で好まれる剤形となっています。従来の錠剤やハードカプセルとは異なり、ソフトカプセルはゼラチンベースのシェルに液体または半固体製剤をカプセル化するため、安定性が向上し、吸収が良くなります。脂溶性ビタミン、オメガ3脂肪酸、ハーブエキス、処方薬などの送達に広く使用されています。便利で無味の経口剤形に対する消費者の嗜好の高まりが、ソフトカプセルの需要をさらに促進しています。さらに、特に免疫力向上やアンチエイジング製品を求める健康志向の消費者の間で栄養補助食品の消費が拡大していることも、市場を強化しています。製薬業界もまた、薬物放出の制御と患者のコンプライアンス向上のためにソフトジェル技術を活用し、現代医療における支配的な経口剤形としての地位を強化しています。

技術革新はソフトカプセル製造をどのように強化しているか？カプセル化と製剤科学の進歩を探る

ソフトジェルカプセル業界では、カプセル化技術と製剤科学が大きく進歩し、製品の品質と汎用性が向上しています。植物性ハイドロコロイドやカラギーナンなどのゼラチン代替物の革新は、ビーガンやベジタリアンの開発につながり、食事制限のある消費者層の増加に対応しています。さらに、マイクロカプセル化技術の進歩により、有効成分の安定性とバイオアベイラビリティが向上し、ソフトカプセルはより効果的なドラッグデリバリーになりました。また、腸溶性コーティングソフトジェルの導入により、遅延放出製剤が可能になり、最適な吸収が確保され、胃への刺激が軽減されました。自動化と連続製造プロセスにより、生産効率はさらに合理化され、製薬会社や栄養補助食品会社はコストを削減し、拡張性を向上させています。ソフトジェルカプセルの製剤を改良する研究が進むにつれて、業界は新たな治療や機能性用途に拡大すると予想されます。

ソフトカプセル市場に影響を与える課題とは？原材料コスト、規制遵守、保存安定性への対応

ソフトカプセルの人気は高まっているもの、原料コスト、厳しい規制要件、安定性に関する課題に直面しています。動物由来のゼラチンを使用しているため、サプライチェーンの持続可能性や価格の変動が懸念されています。さらに、情勢の規制状況は地域によって異なるため、メーカーは厳しい品質管理と表示基準を満たす必要があります。安定性の問題、特に湿気に敏感な製剤や熱に敏感な製剤も、ソフトジェルの製造と保管における課題となっています。こうした懸念に対処するには、代替カプセル素材への投資、進化する医薬品規制への対応、製品の耐久性を向上させる安定性向上賦形剤の進歩が必要です。

ソフトカプセル市場の成長を促すものは何か？主要な業界拡大動向と消費者の嗜好の特定

ソフトカプセル市場の成長は、栄養補助食品に対する消費者需要の増加、カプセル化技術の進歩、医薬品における患者に優しい剤形の採用増加など、いくつかの要因によって牽引されています。健康志向のライフスタイルの急増は、特に新興国市場においてソフトジェルをベースとしたビタミン、ミネラル、ハーブサプリメントの消費を促進しています。さらに、機能性食品やコスメシューティカルの拡大により、美容やスキンケア製品にソフトジェルを利用する新たな機会がもたらされました。鎮痛剤、心血管系、抗炎症剤における医薬品セクターのソフトジェル嗜好は、市場の成長をさらに強化しています。カプセルの設計と成分の安定性における継続的な技術革新により、ソフトカプセル市場は持続的な拡大が見込まれ、消費者とヘルスケアプロバイダーに信頼性が高く効率的なドラッグデリバリーソリューションを提供しています。

セグメント

タイプ（ゼラチンベース／動物性ベース、非動物性ベース）、用途（制酸剤・整腸剤、抗貧血剤、抗炎症剤、抗生物質・抗菌剤、咳・風邪薬、健康補助食品、ビタミン・栄養補助食品、妊娠）、最終用途（製薬会社、栄養補助食品会社、化粧品会社、製造受託機関）

調査対象企業の例

• Aenova Group GmbH
• Algen Healthcare
• Biborick Pharma
• Biofield Pharma
• Capsugel（Lonza）
• CAPTEK Softgel International Inc.
• Catalent, Inc.
• Curivo Healthcare
• Curtis Health Caps
• Delpharm Evreux
• Emcure Pharmaceuticals Limited
• Estrellus
• EuroCaps Ltd
• Fuji Capsule Co., Ltd.
• Greenwell Lifesciences
• Guangdong Yichao Biological Co., Ltd.
• Hunan ER-KANG Pharmaceutical Co Ltd
• KD Pharma Group
• Lifecare Neuro Products Ltd
• Lifevision Healthcare
• MEDGEL Private Limited
• Olive Healthcare
• Procaps Group
• Saphnix Life Sciences
• Sirio Pharma Company Ltd
• Soft Gel Technologies, Inc.
• Strides Pharma Science Limited
• Swisschem Healthcare
• Windzor Pharma Ltd
• ZYUS Life Sciences Inc.

AIインテグレイションズ

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Softgel Capsules Market to Reach US$11.4 Billion by 2030

The global market for Softgel Capsules estimated at US$8.5 Billion in the year 2024, is expected to reach US$11.4 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Gelatin-based / Animal-based, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$7.4 Billion by the end of the analysis period. Growth in the Non-Animal-based segment is estimated at 6.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 7.8% CAGR

The Softgel Capsules market in the U.S. is estimated at US$2.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Softgel Capsules Market - Key Trends & Drivers Summarized

Why Are Softgel Capsules Gaining Market Popularity? Understanding Their Role in Pharmaceuticals, Nutraceuticals, and Cosmetics

Softgel capsules have become a preferred dosage form in the pharmaceutical, nutraceutical, and cosmetic industries due to their ease of consumption, enhanced bioavailability, and extended shelf life. Unlike traditional tablets or hard capsules, softgel capsules encapsulate liquid or semi-solid formulations in a gelatin-based shell, offering improved stability and better absorption. They are widely used for delivering fat-soluble vitamins, omega-3 fatty acids, herbal extracts, and prescription medications. The growing consumer preference for convenient and tasteless oral dosage forms has further fueled the demand for softgel capsules. Additionally, the expansion of dietary supplement consumption, particularly among health-conscious consumers seeking immunity-boosting and anti-aging products, has strengthened the market. The pharmaceutical industry has also leveraged softgel technology for controlled drug release and improved patient compliance, reinforcing its position as a dominant oral dosage form in modern medicine.

How Are Technological Innovations Enhancing Softgel Capsule Manufacturing? Exploring Advancements in Encapsulation and Formulation Science

The softgel capsule industry has witnessed significant advancements in encapsulation techniques and formulation science, improving product quality and versatility. Innovations in gelatin alternatives, such as plant-based hydrocolloids and carrageenan, have led to the development of vegan and vegetarian softgel capsules, catering to a growing segment of consumers with dietary restrictions. Additionally, advances in microencapsulation technology have enhanced the stability and bioavailability of active ingredients, making softgel capsules more effective for targeted drug delivery. The introduction of enteric-coated softgels has also allowed for delayed release formulations, ensuring optimal absorption and reducing gastric irritation. Automation and continuous manufacturing processes have further streamlined production efficiency, reducing costs and improving scalability for pharmaceutical and nutraceutical companies. As research continues to refine softgel capsule formulations, the industry is expected to expand into new therapeutic and functional applications.

What Challenges Are Affecting the Softgel Capsules Market? Addressing Raw Material Costs, Regulatory Compliance, and Shelf Stability

Despite their growing popularity, softgel capsules face challenges related to raw material costs, strict regulatory requirements, and stability concerns. The use of gelatin, derived from animal sources, has raised concerns over supply chain sustainability and pricing fluctuations. Additionally, the regulatory landscape for softgel capsules varies across different regions, requiring manufacturers to meet stringent quality control and labeling standards. Stability issues, particularly for moisture-sensitive or heat-sensitive formulations, have also posed challenges in softgel manufacturing and storage. Addressing these concerns requires investments in alternative capsule materials, compliance with evolving pharmaceutical regulations, and advancements in stability-enhancing excipients to improve product durability.

What’s Driving the Growth of the Softgel Capsules Market? Identifying Key Industry Expansion Trends and Consumer Preferences

The growth in the softgel capsules market is driven by several factors, including increasing consumer demand for nutritional supplements, advancements in encapsulation technology, and rising adoption of patient-friendly dosage forms in pharmaceuticals. The surge in health-conscious lifestyles has encouraged the consumption of softgel-based vitamins, minerals, and herbal supplements, particularly in developed markets. Additionally, the expansion of functional foods and cosmeceuticals has introduced new opportunities for softgel delivery in beauty and skincare products. The pharmaceutical sector’s preference for softgels in pain relief, cardiovascular, and anti-inflammatory medications has further strengthened market growth. With continuous innovation in capsule design and ingredient stability, the softgel capsules market is expected to see sustained expansion, offering consumers and healthcare providers a reliable and efficient drug delivery solution.

SCOPE OF STUDY:

The report analyzes the Softgel Capsules market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Gelatin-based / Animal-based, Non-Animal-based); Application (Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement, Vitamin & Dietary Supplement, Pregnancy); End-Use (Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Contract Manufacturing Organizations)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Aenova Group GmbH
• Algen Healthcare
• Biborick Pharma
• Biofield Pharma
• Capsugel (Lonza)
• CAPTEK Softgel International Inc.
• Catalent, Inc.
• Curivo Healthcare
• Curtis Health Caps
• Delpharm Evreux
• Emcure Pharmaceuticals Limited
• Estrellus
• EuroCaps Ltd
• Fuji Capsule Co., Ltd.
• Greenwell Lifesciences
• Guangdong Yichao Biological Co., Ltd.
• Hunan ER-KANG Pharmaceutical Co Ltd
• KD Pharma Group
• Lifecare Neuro Products Ltd
• Lifevision Healthcare
• MEDGEL Private Limited
• Olive Healthcare
• Procaps Group
• Saphnix Life Sciences
• Sirio Pharma Company Ltd
• Soft Gel Technologies, Inc.
• Strides Pharma Science Limited
• Swisschem Healthcare
• Windzor Pharma Ltd
• ZYUS Life Sciences Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Softgel Capsules - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Easy-to-Swallow, Bioavailable Oral Dosage Forms Throws the Spotlight on Softgel Capsules
  • Growth in Nutraceutical and OTC Supplement Market Spurs Consumption of Softgel-Based Delivery Systems
  • OEM Innovation in Gelatin and Vegan Alternative Shells Expands Consumer Acceptance and Market Reach
  • Expansion of Oil-Based APIs and Lipophilic Actives Supports Formulation in Softgel Format
  • OEM Emphasis on Controlled Release, Enteric Coating, and Odor Masking Enhances Drug Stability
  • Increasing Use in Omega-3, Vitamins, and Herbal Extract Supplements Supports Daily Health Product Demand
  • OEM Development of Twin-Shell, Liquid-Fill, and Semi-Solid Formulations Drives Product Customization
  • Rising Consumer Preference for Transparent Capsules and Clean Label Claims Supports Natural Formulation Trends
  • OEM Integration of High-Speed Encapsulation, Leak-Proof Sealing, and Uniform Fill Weight Enhances Quality Control
  • Growth in Contract Manufacturing Services Supports Small and Medium Brand Entry Into Competitive Markets
  • OEM Focus on Advanced Printing and Brand Differentiation Technologies Enhances Market Visibility
  • Expansion of Pediatric and Geriatric Therapeutics Supports Use in Non-Chewable, Taste-Masked Delivery
  • OEM Partnerships With Nutraceutical and Functional Food Brands Accelerate Launch of New SKUs
  • Rising Demand for Shelf-Stable, Moisture-Protected Supplements Strengthens Blister and Bottle Packaging Innovation
  • OEM Strategies for Multi-Compartment Capsules and Dual Action Therapies Support Complex Formulations
  • Surge in Personalized Supplementation Models Supports Small Batch, Custom Softgel Production
  • OEM Investment in Kosher, Halal, and Non-GMO Certifications Enhances Global Export Potential
  • Growth in Cold-Pressed Oils, CBD, and Botanical Oils Supports Use of Oil-Soluble Fill Formats
  • OEM Emphasis on Global Regulatory Compliance, Gelatin Sourcing Transparency, and BSE-Free Supply Chains Strengthens Trust
  • Focus on Digestive Comfort, Quick Absorption, and Dose Uniformity Enhances Softgel Preference Over Tablets
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Softgel Capsules Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Softgel Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Softgel Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Softgel Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Gelatin-based / Animal-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Gelatin-based / Animal-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Gelatin-based / Animal-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Non-Animal-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Non-Animal-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Non-Animal-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Pregnancy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Pregnancy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Pregnancy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Antacid & Anti-Flatulent Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Antacid & Anti-Flatulent Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Antacid & Anti-Flatulent Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Anti-Anemic Preparations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Anti-Anemic Preparations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Anti-Anemic Preparations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Anti-Inflammatory Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Antibiotic & Antibacterial Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Antibiotic & Antibacterial Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Antibiotic & Antibacterial Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Cough & Cold Preparations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Cough & Cold Preparations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Cough & Cold Preparations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Health Supplement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Health Supplement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Health Supplement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Vitamin & Dietary Supplement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Vitamin & Dietary Supplement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Vitamin & Dietary Supplement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Nutraceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Nutraceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Nutraceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Cosmeceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Cosmeceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Cosmeceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Contract Manufacturing Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Contract Manufacturing Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Contract Manufacturing Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• JAPAN
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• CHINA
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• EUROPE
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Softgel Capsules by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Softgel Capsules by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Softgel Capsules by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• FRANCE
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 95: France Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• GERMANY
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 122: UK Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: UK 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Spain 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Russia 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Softgel Capsules by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Softgel Capsules by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Australia 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• INDIA
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 179: India Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: India 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: South Korea 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Softgel Capsules by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Softgel Capsules by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Softgel Capsules by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Argentina 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Brazil 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Mexico 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Softgel Capsules by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Softgel Capsules by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Softgel Capsules by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Iran 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Israel 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: UAE 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
• AFRICA
  • Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Africa 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030

IV. COMPETITION